Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37203-1738, USA.
Cancer Causes Control. 2011 Sep;22(9):1319-31. doi: 10.1007/s10552-011-9805-9. Epub 2011 Jun 28.
The After Breast Cancer Pooling Project was established to examine the role of physical activity, adiposity, dietary factors, supplement use, and quality of life (QOL) in breast cancer prognosis. This paper presents pooled and harmonized data on post-diagnosis lifestyle factors, clinical prognostic factors, and breast cancer outcomes from four prospective cohorts of breast cancer survivors (three US-based and one from Shanghai, China) for 18,314 invasive breast cancer cases diagnosed between 1976 and 2006. Most participants were diagnosed with stage I-II breast cancer (84.7%). About 60% of breast tumors were estrogen receptor (ER)+/progesterone receptor (PR)+; 21% were ER-/PR-. Among 8,118 participants with information on HER-2 tumor status, 74.8% were HER-2- and 18.5% were HER-2+. At 1-2 years post-diagnosis (on average), 17.9% of participants were obese (BMI ≥ 30 kg/m2), 32.6% were overweight (BMI 25-29 kg/m2), and 59.9% met the 2008 Physical Activity Guidelines for Americans (≥ 2.5 h per week of moderate activity). During follow-up (mean = 8.4 years), 3,736 deaths (2,614 from breast cancer) and 3,564 recurrences have been documented. After accounting for differences in year of diagnosis and timing of post-diagnosis enrollment, five-year overall survival estimates were similar across cohorts. This pooling project of 18,000 breast cancer survivors enables the evaluation of associations of post-diagnosis lifestyle factors, QOL, and breast cancer outcomes with an adequate sample size for investigation of heterogeneity by hormone receptor status and other clinical predictors. The project sets the stage for international collaborations for the investigation of modifiable predictors for breast cancer outcomes.
乳腺癌后群组研究项目旨在研究体力活动、肥胖、饮食因素、补充剂使用和生活质量(QOL)在乳腺癌预后中的作用。本文介绍了来自四个前瞻性乳腺癌幸存者队列(三个来自美国,一个来自中国上海)的 18314 例浸润性乳腺癌病例的发病后生活方式因素、临床预后因素和乳腺癌结局的汇总和协调数据,这些病例诊断于 1976 年至 2006 年之间。大多数参与者被诊断为 I 期-II 期乳腺癌(84.7%)。约 60%的乳腺癌肿瘤为雌激素受体(ER)+/孕激素受体(PR)+;21%为 ER-/PR-。在 8118 名有 HER-2 肿瘤状态信息的参与者中,74.8%为 HER-2-,18.5%为 HER-2+。在诊断后 1-2 年内(平均),17.9%的参与者肥胖(BMI≥30kg/m2),32.6%超重(BMI 25-29kg/m2),59.9%符合 2008 年《美国人身体活动指南》(每周进行 2.5 小时以上的中度活动)。在随访期间(平均=8.4 年),记录了 3736 例死亡(2614 例死于乳腺癌)和 3564 例复发。在考虑到诊断年份和发病后入组时间的差异后,五个年总体生存率估计在各队列中相似。这项对 18000 名乳腺癌幸存者的汇总研究使得能够评估发病后生活方式因素、QOL 和乳腺癌结局与激素受体状态和其他临床预测因素的异质性研究的关联,具有足够的样本量。该项目为国际合作研究乳腺癌结局的可改变预测因素奠定了基础。